Protein chip for the parallel quantification of high and low abundant biomarkers for sepsis.

We present herein a protein chip for diagnosis of sepsis that combines both a sandwich and a binding inhibition format in order to quantify high (CRP) and low abundant proteins (cytokines, PCT, neopterin) in parallel. Using the combined assay format the lowest detectable concentrations for CRP, IL-6, IL-8, IL-10, TNFα, PCT, and neopterin are 3 mg/L, 15 ng/L, 26 ng/L, 65 ng/L, 40 ng/L, 78 ng/L, and 0.46 μg/L. Four different combined assay formats are tested, using separate or joint incubation steps of analytes and detection antibodies. Yet, low limit of detection (LOD) and short processing time are contradictory: while the combined assay performed in a multistep protocol is extremely sensitive (e.g., the LOD for IL-6 is 15 ng/L), but more time-consuming (4 h), the all-in-one protocol takes only 2.5 h, but suffers from lower sensitivity compared with the multistep protocol (e.g., the LOD for IL-6 is up to 40 times enhanced). Reproducibility is good in both cases (CV 5-20%).

[1]  C. Mitaka.  Clinical laboratory differentiation of infectious versus non-infectious systemic inflammatory response syndrome. , 2005, Clinica chimica acta; international journal of clinical chemistry.

[2]  Melanie Kess,et al.  Multi-parameter determination of TNFα, PCT and CRP for point-of-care testing. , 2011, The Analyst.

[3]  Guenter Gauglitz,et al.  Two immunoassay formats for fully automated CRP detection in human serum , 2008, Analytical and bioanalytical chemistry.

[4]  A. Madan,et al.  Serial Serum C-Reactive Protein Levels in the Diagnosis of Neonatal Infection , 1998, Pediatrics.

[5]  Ursula Sauer,et al.  Protein microarray for the analysis of human melanoma biomarkers , 2009 .

[6]  S. Kingsmore,et al.  Identification of Diagnostic Biomarkers for Infection in Premature Neonates* , 2008, Molecular & Cellular Proteomics.

[7]  H. Wachter.  Neopterin : biochemistry, methods, clinical application , 1992 .

[8]  C. Gogos,et al.  Pro- versus anti-inflammatory cytokine profile in patients with severe sepsis: a marker for prognosis and future therapeutic options. , 2000, The Journal of infectious diseases.

[9]  M. Meisner,et al.  Clinical Experiences with a New Semi-Quantitative Solid Phase Immunoassay for Rapid Measurement of Procalcitonin , 2000, Clinical chemistry and laboratory medicine.

[10]  D. Fuchs,et al.  Performance of a fully automated quantitative neopterin measurement assay in a routine voluntary blood donation setting , 2010, Clinical chemistry and laboratory medicine.

[11]  U. Sungurtekin,et al.  Usefulness of procalcitonin for diagnosis of sepsis in the intensive care unit , 2002, Critical care.

[12]  A. Vernallis,et al.  Pro-inflammatory cytokines IL6, TNF-α, IL1β, procalcitonin, lipopolysaccharide binding protein and C-reactive protein in infective endocarditis , 2007 .

[13]  Albrecht Brandenburg,et al.  Compact point-of-care system for clinical diagnostics , 2009 .

[14]  T. Bertsch,et al.  Evaluation of a New Simple and Rapid Enzyme-Linked Immunosorbent Assay Kit for Neopterin Determination , 2000, Clinical chemistry and laboratory medicine.

[15]  F Baldini,et al.  A new optical platform for biosensing based on fluorescence anisotropy , 2008, Analytical and bioanalytical chemistry.

[16]  T F Fok,et al.  Diagnosis of late onset neonatal sepsis with cytokines, adhesion molecule, and C-reactive protein in preterm very low birthweight infants , 1997, Archives of disease in childhood. Fetal and neonatal edition.

[17]  D. Fuchs,et al.  Value of serum procalcitonin, neopterin, and C-reactive protein in differentiating bacterial from viral etiologies in patients presenting with lower respiratory tract infections. , 2007, Diagnostic microbiology and infectious disease.

[18]  Ursula Sauer,et al.  Quick and simple: quality control of microarray data , 2005, Bioinform..